RARE PHOTOS: 7 | Rare Historical Photos

Reducing eating hours may cut risk of dementia, research suggests

The findings suggest that weight loss and restricted eating times can ward off age-related cognitive decline, the study’s principle investigator says

The Independent UK · Jul 27

Millions of people are losing weight using GLP-1s. How do the drugs affect their love lives?

Prescribing doctors often warn of the medications’ potential side-effects – but unexpected impacts on romantic relationships are less understood

The Guardian - AU · Jul 25

10 Cancer Warning Signs Oncologists Say Shouldn’t Be Ignored

Most people experience aches, fatigue, or digestive issues from time to time, and in most cases those symptoms have harmless explanations. However, oncologists consistently emphasize that persistent or unexplained changes deserve medical attention rather than being brushed aside. Early detection remains one of the biggest factors influencing successful cancer treatment,…

Budget and the Bees · Jul 25

GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients

A July 2026 JCEM study found semaglutide and tirzepatide linked to greater hip bone loss, especially in people without diabetes. Here's what GLP-1 patients need to know now.

Medical Daily · Jul 24

Doctors Sound Alarm as Popular Weight Loss Drugs Wegovy and Mounjaro Are Linked to Sudden Hair Loss

Wegovy and Mounjaro are linked to a higher risk of hair loss in a major study, with researchers pointing to rapid weight loss and possible iron, zinc and biotin deficiencies.

International Business Times UK · Jul 23

The New Drug Melting Body Fat From 38% To 22% — And The Side Effect Patients Are Ignoring

A new weight loss drug is drawing serious attention from the medical community, and the comparisons to Ozempic are coming quickly. But researchers are pointing to one difference between the two that is proving difficult to overlook, and it may change how the conversation around weight loss medication develops from…

Bored Panda · Jul 23

Medicare's New GLP-1 Weight Loss Drug Program Launched July 1, but It Expires in 2027 with No Successor in Place

The Medicare GLP-1 Bridge launched July 1, 2026 at $50/month for eligible beneficiaries. It expires December 31, 2027, with the permanent BALANCE replacement indefinitely delayed.

Medical Daily · Jul 23

The First Oral GLP-1 Weight Loss Pill With No Food or Injection Requirements Is Now Available

Eli Lilly's Foundayo (orforglipron) is the first oral GLP-1 obesity pill with no food or water restrictions. FDA approved it April 1, 2026. Here is what patients should know.

Medical Daily · Jul 23

Man Loses 110 Lbs And Joins A Chinese Fat Camp, Says The Most Powerful Part Was Not The Weight

Weight loss content is everywhere. Before and afters, transformation reels, supplement ads disguised as testimonials- the internet is absolutely saturated with it, and most of it follows the same formula. But every now and then someone comes along with a story that cuts through all of that noise because it…

Bored Panda · Jul 23

'What's Going on With Her?' Serena Williams' Knee Recovery Update Sparks Fan Concern Over Apparent Weight Loss

Serena Williams' latest knee recovery video reassured fans about her rehabilitation, but many instead questioned her apparent weight loss following her Wimbledon withdrawal.

International Business Times UK · Jul 23